Medtronic initiated the recall of certain Pipeline Vantage embolisation devices in January 2025 following reports of four ...
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
Medtronic (MDT) stock turned lower as the FDA announced a most serious type of recall involving its Pipeline Vantage 027 ...
The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
Medtronic's recall of embolization device has been classified most serious by the U.S. Food and Drug Administration (USFDA), ...
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's (MDT.N), opens new tab embolization device as "most serious", following reports of the ...
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
Image credit: Tada Images / Shutterstock The US Food and Drug Administration (FDA) has tagged Medtronic’s recall of certain Pipeline Vantage embolisation devices as Class I following reports of four ...